British scientists have developed “the first reliable test of whether men are at high risk of prostate cancer”, reported the Daily Mail.
It said test has so far proven to be twice as precise as the existing PSA test, and it is also of synthetic urine rather than blood, which would to become cheaper to performance.Prostate cancer is the most popular cancer in men, affecting , men in the UK a year, with , of those dying from the disease. This research implies that men with the disease have reduced stages of a protein called MSMB. This is very early laboratory research, and it is just too early to advise that the test “offers hope to thousands”.
It still is not known whether an experiment based on this research could improve prediction of prostate type of cancer risk, prostate cancer diagnosis or disease watching. Larger studies within the community are needed before currently have a better idea of whether programs are due to could manifest as an useful accessory for the existing tests for prostate cancer. The study was carried out by researchers from the cancer Research UK CRUK Cambridge Research Institute and study centres inside the UK, US and Down under. It was funded by the University of Cambridge, CRUK, The Institute of Cancer Research, The Everyman Campaign, the EU, Hutchison Whampoa Limited and the Prostate Cancer Research Facial foundation.
The study was published in the peerreviewed openaccess journal PLoS ONE. The Daily Mail, The Guardian, BBC News and The Daily Telegraph covered this story. They suggest that the test possibly be able in order to people at greater likelihood of prostate cancer and might be part associated with screening programme.However, some of the reports can provide the wrong impression of how developed this test is. Product sales is still at first stage, additionally it is unknown whether this protein could be used to detect those at the upper chances of prostate cancer, or how long it normally requires to become commercially at one’s disposal.